More on Personalization

I write about personalization a lot, partly because it's in the "cancer news" cycle a lot, but also because it's pretty exciting.

The latest: a study from Weill-Cornell (reported on their very excellent blog, "New Developments in Lymphoma," on a collaboration with Sloan-Kettering and the National Cancer Institute.The research team found a compound called PU-H71 that can reveal the pathways in cells that have been changed, resulting in cancer. Once the pathways have been revealed, treatments can be created that will target them. That's where the personalization comes in. Each individual's cancer is a little different, so revealing the individual pathways will help uncover those individual differences.

The original research is published in the journal Nature Chemical Biology, in an article called "Affinity-Based Proteomics Reveal Cancer-Specific Networks Coordinated by Hsp90."

One more step in the right direction.